These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 6801075

  • 21. Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women.
    Meldrum DR, Tsao Z, Monroe SE, Braunstein GD, Sladek J, Lu JK, Vale W, Rivier J, Judd HL, Chang RJ.
    J Clin Endocrinol Metab; 1984 Apr; 58(4):755-7. PubMed ID: 6365947
    [Abstract] [Full Text] [Related]

  • 22. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
    Rosenfield RL, Garibaldi LR, Moll GW, Watson AC, Burstein S.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712
    [Abstract] [Full Text] [Related]

  • 23. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
    Pavlou SN, Dahl KD, Wakefield G, Rivier J, Vale W, Hsueh AJ, Lindner J.
    J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
    [Abstract] [Full Text] [Related]

  • 24. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM, Comite F, Pescovitz OH, Ross JL, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [Abstract] [Full Text] [Related]

  • 25. Absence of immunoreactive luteinizing hormone following gonadotropin-releasing hormone agonist therapy in women with endometriosis.
    Bischof P, Herrmann WL.
    Gynecol Obstet Invest; 1988 Oct; 25(2):130-4. PubMed ID: 2967234
    [Abstract] [Full Text] [Related]

  • 26. More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children.
    Wide L, Albertsson-Wikland K, Phillips DJ.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):216-21. PubMed ID: 8550754
    [Abstract] [Full Text] [Related]

  • 27. Early and late hormonal responses to the microdose gonadotropin-releasing hormone agonist in normal menstruating women.
    Park WI, Kim SS, Chung HR, Shin SY, Lee JY.
    Fertil Steril; 2004 Apr; 81(4):1067-72. PubMed ID: 15066465
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Direct inhibition of testicular steroidogenesis and gonadotrophin receptor levels by [(imBzl)-D-His6, Pro9-NEt]GnRH and [D-Trp6, Pro9-NEt]GnRH, potent agonists of GnRH.
    Cao YQ, Sundaram K, Bardin CW, Rivier J, Vale W.
    Int J Androl; 1982 Apr; 5(2):158-70. PubMed ID: 6286508
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
    Filicori M, Flamigni C, Cognigni G, Dellai P, Arnone R, Falbo A, Capelli M.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):130-3. PubMed ID: 8325935
    [Abstract] [Full Text] [Related]

  • 34. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF, Crawford JD, Crowley WF.
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [Abstract] [Full Text] [Related]

  • 35. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW, Gordon K, Billiar RB, Little AB.
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [Abstract] [Full Text] [Related]

  • 36. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G, Linde R, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D.
    Int J Fertil; 1982 Mar; 27(4):234-7. PubMed ID: 6131043
    [Abstract] [Full Text] [Related]

  • 37. Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH2(10)]LH-RH ethylamide.
    Dupont A, Dupont P, Belanger A, Mailoux J, Cusan L, Labrie F.
    Fertil Steril; 1990 Aug; 54(2):227-32. PubMed ID: 2199228
    [Abstract] [Full Text] [Related]

  • 38. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.